Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Nigam M. Mishra"'
Autor:
Nigam M. Mishra, Izabela Stolarzewicz, David Cannaerts, Joris Schuermans, Rob Lavigne, Yannick Looz, Bart Landuyt, Liliane Schoofs, Dominique Schols, Jan Paeshuyse, Peter Hickenbotham, Martha Clokie, Walter Luyten, Erik V. Van der Eycken, Yves Briers
Publikováno v:
Frontiers in Microbiology, Vol 9 (2018)
Vancomycin is a glycopeptide antibiotic that inhibits transpeptidation during cell wall synthesis by binding to the D-Ala-D-Ala termini of lipid II. For long, it has been used as a last resort antibiotic. However, since the emergence of the first van
Externí odkaz:
https://doaj.org/article/0b2f49f11e0a456f9270736b181fd597
Autor:
Alshaima'a M. Qunies, Nigam M. Mishra, Brittany D. Spitznagel, Yu Du, Valerie S. Acuña, C. David Weaver, Kyle A. Emmitte
Publikováno v:
Bioorganicmedicinal chemistry letters. 76
In this Letter we describe structure-activity relationship (SAR) studies conducted in five distinct regions of a new 2-amino-N-phenylacetamides series of Slack potassium channel inhibitors exemplified by recently disclosed high-throughput screening (
Autor:
Corinna Schüß, Kyle A. Emmitte, Jan Stichel, Oanh Vu, Jens Meiler, C. David Weaver, Helen M. Cox, Nigam M. Mishra, Iain R. Tough, Annette G. Beck-Sickinger, Mario Schubert, Yu Du
Publikováno v:
Journal of Medicinal Chemistry. 64:2801-2814
Human neuropeptide Y receptors (Y1R, Y2R, Y4R, and Y5R) belong to the superfamily of G protein-coupled receptors and play an important role in the regulation of food intake and energy metabolism. We identified and characterized the first selective Y4
Autor:
Yu Du, Francis J. Prael, Nigam M. Mishra, Kyle A. Emmitte, Alshaima’a M. Qunies, Jerod S. Denton, Brittany D. Spitznagel, C. David Weaver, Roman M. Lazarenko, Krystian A. Kozek
Publikováno v:
ACS Chemical Neuroscience. 11:3658-3671
Malignant migrating partial seizures of infancy is a rare, devastating form of epilepsy most commonly associated with gain-of-function mutations in the potassium channel, Slack. Not only is this condition almost completely pharmacoresistant, there ar
Autor:
Corinna, Schüß, Oanh, Vu, Mario, Schubert, Yu, Du, Nigam M, Mishra, Iain R, Tough, Jan, Stichel, C David, Weaver, Kyle A, Emmitte, Helen M, Cox, Jens, Meiler, Annette G, Beck-Sickinger
Publikováno v:
Journal of medicinal chemistry. 64(5)
Human neuropeptide Y receptors (Y
Autor:
Rohit Sampat, Jin Liu, Kyle A. Emmitte, Nigam M. Mishra, Yu-Chieh Wang, Hamed S. Hayatshahi, Abhishek Parab, Ashwini Zolekar, Xiaoyan Liao, Yin Ying Ho, Victor Lin, Peter Hoffmann
Publikováno v:
British Journal of Cancer
Background Although NGLY1 is known as a pivotal enzyme that catalyses the deglycosylation of denatured glycoproteins, information regarding the responses of human cancer and normal cells to NGLY1 suppression is limited. Methods We examined how NGLY1
Autor:
Matteo Pagliari, Marina de Bernard, Francesca Vallese, Paola Berto, Nigam M. Mishra, Gaia Codolo, Giuseppe Zanotti
Publikováno v:
Biochimica et Biophysica Acta (BBA) - General Subjects. 1861:3263-3271
Background Helicobacter pylori is a bacterium that affects about 50% of the world population and, despite being often asymptomatic, it is responsible of several gastric diseases, from gastritis to gastric cancer. The protein Lpp20 (HP1456) plays an i
Autor:
Jin Liu, Ashwini Zolekar, Yin Ying Ho, Kyle A. Emmitte, Abhishek Parab, Nigam M. Mishra, Peter Hoffmann, Rohit Sampat, Hamed S. Hayatshahi, Yu-Chieh Wang, Victor Lin, Xiaoyan Liao
Publikováno v:
Cancer Research. 80:A28-A28
Although NGLY1 is known as a pivotal enzyme that catalyzes the deglycosylation of denatured glycoproteins, information regarding the responses of human cancer and normal cells to NGLY1 suppression is limited. While studying the NGLY1 deficiency-cause
Publikováno v:
Advanced Synthesis & Catalysis. 356:1029-1037
A simple protocol for the synthesis of mono-propargylic amines (IV), (VI), (VIII), (XI), and (XIV) as well as symmetrical dipropargylic amines (XV) from α-amino esters, aldehydes or ketones, and alkynes.
Autor:
Victor J.T. Lin, Ashwini Zolekar, Nigam M. Mishra, Yin Ying Ho, Hamed S. Hayatshahi, Abhishek Parab, Rohit Sampat, Xiaoyan Liao, Peter Hoffmann, Jin Liu, Kyle A. Emmitte, Yu-Chieh Wang
Publikováno v:
Cancer Research. 79:3048-3048
As an enzyme that removes N-glycans from glycopeptides, N-glycanase 1 (NGLY1) deglycosylates denatured glycoproteins and allows proteasome-mediated protein degradation to efficiently occur. Although NGLY1 is known for this pivotal function, informati